Published in Lancet on August 20, 1994
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet (1999) 6.69
Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol (1974) 3.56
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94
Visual capacity in the hemianopic field following a restricted occipital ablation. Brain (1974) 2.92
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Benign retinal vasculitis. Clinical and fluorescein angiographic study. Br J Ophthalmol (1971) 2.32
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Viscosity and retinal vein thrombosis. Br J Ophthalmol (1976) 2.12
Fluorescein fundus photography in the detection of early papilloedema and its differentiation from pseudo-papilloedema. Lancet (1965) 2.12
Hypoxic ocular sequelae of carotid-cavernous fistulae. Study of the caues of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol (1969) 2.11
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients. Brain (1973) 1.94
The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost (2013) 1.92
Factors affecting visual loss in benign intracranial hypertension. Ophthalmology (1984) 1.89
Venous thromboembolism after acute stroke. Stroke (2001) 1.81
Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol (1998) 1.81
Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology (1982) 1.79
Computer assisted tomography in orbital disease. Br J Ophthalmol (1974) 1.79
Ischaemic papillopathy. Trans Ophthalmol Soc U K (1971) 1.79
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
Heparin-induced skin reaction due to two different preparations of low molecular weight heparin (LMWH) Br J Haematol (1993) 1.73
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol (1998) 1.67
Fluorescein angiography in the diagnosis of drusen of the disc. Trans Ophthalmol Soc U K (1967) 1.62
Severe decompression retinopathy after medical treatment of acute primary angle closure. Br J Ophthalmol (2007) 1.59
Questioning questionnaires. Eye (Lond) (2001) 1.58
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol (1981) 1.52
Activated protein C and retinal vein occlusion. Br J Ophthalmol (1996) 1.47
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Ophthalmoplegia in carotid cavernous sinus fistula. Br J Ophthalmol (1984) 1.43
Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost (2005) 1.43
The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur J Cardiothorac Surg (1995) 1.43
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Role of D-dimers in diagnosis of venous thromboembolism. Lancet (2002) 1.42
Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke (2004) 1.42
Intraocular tuberculosis. Eye (Lond) (1990) 1.42
Retinal vasculitis: a review. J R Soc Med (1979) 1.41
The effects of aprotinin on thromboelastography with three different activators. Anesthesiology (2001) 1.41
Retinal, choroidal, and optic disc involvement in sarcoidosis. Trans Ophthalmol Soc U K (1976) 1.41
Bilateral sudden visual loss due to sphenoid mucocele in Albright's syndrome. Br J Ophthalmol (1995) 1.40
The new oral anticoagulants. Clin Med (2011) 1.40
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: a report of two cases. Br J Dermatol (2000) 1.39
The ocular complications of HIV and AIDS. Int J STD AIDS (1997) 1.38
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Migraine complicated by ischaemic papillopathy. Lancet (1971) 1.35
"Blindsight": Vision in a field defect. Lancet (1974) 1.32
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Papilledema and asymptomatic intracranial hypertension in systemic lupus erythematosus. A fluorescein angiographic study of resolving papilledema. Arch Ophthalmol (1968) 1.29
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain (1994) 1.22
Neurophysiological investigation in optic nerve disease: combined assessment of the visual evoked response and electroretinogram. Br J Ophthalmol (1978) 1.19
The retinal manifestations of mitochondrial myopathy. A study of 22 cases. Arch Ophthalmol (1985) 1.18
Dehydration and venous thromboembolism after acute stroke. QJM (2004) 1.18
Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol (2005) 1.18
Scleral canal size and optic nerve head drusen. Am J Ophthalmol (1985) 1.17
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No. J Thromb Haemost (2005) 1.14
Late onset Leber's optic neuropathy: a case confused with ischaemic optic neuropathy. Br J Ophthalmol (1992) 1.14
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
Differential diagnosis of unilateral optic disc oedema. Trans Ophthalmol Soc U K (1980) 1.13
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus. Transplantation (2000) 1.12
Papilloedema, a complication of progressive diaphyseal dysplasia: a series of three case reports. Br J Ophthalmol (1998) 1.12
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K (1985) 1.08
Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry (1986) 1.07
Computerized tomographic scanning (EMI scan) in neuro-ophthalmology. Trans Ophthalmol Soc U K (1975) 1.07
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Neurological abnormalities in congenital amaurosis of Leber. Review of 30 cases. Arch Dis Child (1977) 1.06
Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth (2004) 1.04
Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology. J Neurol Neurosurg Psychiatry (1998) 1.04
ACE inhibitors after myocardial infarction: patient selection or treatment for all? Br Heart J (1995) 1.03
A classification of papilloedema based on a fluorescein angiographic study of 69 cases. Trans Ophthalmol Soc U K (1970) 1.03
Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard (1999) 1.02
Ocular and nervous system involvement in angioma serpiginosum. Br J Ophthalmol (1971) 1.02
Choroidal folds in association with papilloedema. Br J Ophthalmol (1973) 1.02
The feasibility of in vivo neutron activation analysis of total body calcium and other elements of body composition. Phys Med Biol (1968) 1.02
An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods (1987) 1.02
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation (2000) 1.02